SCHEMBL12240

SCHEMBL12240

CS(=O)(=O)CCC(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL10583532 0.97 APEX1 (0.57)
SCHEMBL1848872 0.83 LMNA (0.50)
SCHEMBL17653549 0.81 LMNA (0.55)
SCHEMBL4004597 0.79 TSHR (0.57)
SCHEMBL21616868 0.79 TSHR (0.57)
SCHEMBL9340855 0.79 TSHR (0.57)
SCHEMBL2567545 0.79 TSHR (0.57)
SCHEMBL28025340 0.79 NLRP3 (0.38)
SCHEMBL11496708 0.79 APEX1 (0.55)
SCHEMBL24129450 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 306 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119281250-A System and process for continuous preparation of 3- (methylsulfonyl) propionic acid 浙江倍合德制药有限公司 2025-01-10 CN claimed
EP-3551633-B1 SUBSTITUTED PYRAZOLOAZEPIN-4-ONES AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS LEO PHARMA AS (DK) 2021-03-31 EP claimed
CN-111108109-A Substituted dihydrothienopyrimidines and their use as phosphodiesterase inhibitors 利奥制药有限公司 2020-05-05 CN claimed
EP-3204363-A1 SUBSTITUTED PYRIMIDINES AS INHIBITORS OF HIF PROLYL HYDROXYLASE Merck Sharp & Dohme Corp. (US) 2017-08-16 EP claimed
WO-2016057762-A1 SUBSTITUTED PYRIMIDINES AS INHIBITORS OF HIF PROLYL HYDROXYLASE MERCK SHARP & DOHME CORP (US) 2016-04-14 WO claimed
US-7893030-B2 Stable chromogenic test reagent and its use in coagulation-diagnostic tests SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH (DE) 2011-02-22 US claimed
US-20060166301-A1 Stable chromogenic test reagent and its use in coagulation-diagnostic tests DADE BEHRING MARBURG GMBH 2006-07-27 US claimed
EP-0270651-A4 NOVEL DEOXYRIBONUCLEOSIDE PHOSPHORAMIDITES AND THEIR USE FOR THE PREPARATION OF OLIGONUCLEOTIDES. CALIFORNIA INST OF TECHN (US) 1989-03-29 EP claimed
EP-0270651-A1 NOVEL DEOXYRIBONUCLEOSIDE PHOSPHORAMIDITES AND THEIR USE FOR THE PREPARATION OF OLIGONUCLEOTIDES. CALIFORNIA INST OF TECHN (US) 1988-06-15 EP claimed
WO-1988000201-A1 NOVEL DEOXYRIBONUCLEOSIDE PHOSPHORAMIDITES AND THEIR USE FOR THE PREPARATION OF OLIGONUCLEOTIDES CALIFORNIA INSTITUTE OF TECHNOLOGY, INC. (US) 1988-01-14 WO claimed
EP-4029868-B1 MCL-1 INHIBITORS GILEAD SCIENCES INC (US) 2026-05-20 EP disclosed
EP-4743454-A1 PYRIMIDINE COMPOUNDS AND THEIR USE AS USP1 INHIBITORS Laekna Pharmaceutical Ningbo Co., Ltd. (CN) 2026-05-20 EP disclosed
US-20250376445-A1 COMPOUNDS AND METHODS FOR YAP/TEAD MODULATION AND INDICATIONS THEREFOR Opna Bio SA (CH) 2025-12-11 US disclosed
EP-4654970-A1 COMPOUNDS AND METHODS FOR YAP/TEAD MODULATION AND INDICATIONS THEREFOR Opna Bio SA (CH) 2025-12-03 EP disclosed
EP-3882252-B1 BETA-LACTAMASE INHIBITORS VENATORX PHARMACEUTICALS INC (US) 2025-11-19 EP disclosed
EP-0108942-A2 Cephalosporin derivatives, methods of production thereof and prophylactic and therapeutic agents for bacterial infection Kyoto Pharmaceutical Industries, Ltd. (JP) 1984-05-23 EP disclosed
US-4400504-A DYEING AND PRINTING CELLULOSE AND POLYAMIDE AND-URETHANE FIBERS; TRIAZINE, PYRIDINE AND PYRIMIDINE DYES BAYER AKTIENGESELLSCHAFT (DE) 1983-08-23 US disclosed
EP-0053743-A2 Reactive dioxazine dyestuffs, process for their preparation and their use in dyeing and printing fibrous materials containing hydroxyle or amide groups BAYER AG (DE) 1982-06-16 EP disclosed
US-4160830-A Cephalosporins TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1979-07-10 US disclosed
US-4065619-A ANTIBIOTIC TAKEDA CHEMICAL INDUSTRIES, LTD. (JA) 1977-12-27 US disclosed